NTA per share fell 11.4% while the benchmark returned +3.2%

NTA per share fell 11.4% to NZ$1.40 while the listed-equity benchmark returned +3.2%, so the fund underperformed a positive market on a unit-NAV basis.

Recurring dividend and interest income, the only stable income line, rose 14.4% to NZ$9.0m (FY22: NZ$7.9m). Net assets attributable to shareholders dropped 8.7% to NZ$461.6m, the lower edge of the four-year range (mean NZ$496.1m). Reported net loss after tax widened to NZ$19.5m from NZ$17.3m.

Total dividends paid during the year were 11.64 cps (FY22: 14.34 cps), with a final dividend of 2.82 cps versus 3.16 cps. Cash held fell to NZ$6.4m from NZ$8.0m.

The benchmark delivered +3.2% while NAV per share fell 11.4%, implying meaningful relative underperformance in a year when peers had a tailwind. For a listed investment company, persistent benchmark deficit is the central question; one weak year is not a verdict, but it compounds with the longer-run pattern Annolyse flags as below-mean returns.

Distribution coverage from income is thin. Recurring investment income of NZ$9.0m covered only 36.7% of the NZ$24.6m of distributions paid during the year. The remainder was funded from capital, which is how the company's dividend reinvestment-style structure typically operates, but it directly contributed to the 8.7% decline in net assets in a year of negative portfolio return.

Income growth is real but small in context. The 14.4% lift in dividend and interest income confirms portfolio companies kept paying through inflation and rate pressure, yet at NZ$9.0m it is less than two-thirds of one quarter's distribution outflow. The recurring income base alone is not sized to fund the current distribution policy if capital values remain under pressure.

Half-year shape context is informative: HY23 carried an NZ$48.4m loss and an NZ$45.9m investment-revenue loss, so the second half delivered an implied NZ$28.9m profit recovery and roughly NZ$55.0m of positive investment revenue. The market rebound through to March 2023 did most of the work in narrowing the full-year loss.

This release does not support a directional read on FY24, but it does set a starting point: NTA at NZ$1.40, a distribution rate already running ahead of income, and a recent record of trailing the benchmark. Closing the relative-return gap matters more than absolute return for an issuer of this type.

The recurring income line is the durable component, and that grew 14.4% on a higher dividend yield from underlying holdings. The unrealised and realised fair-value movements that drove the headline loss are mark-to-market in character and reverse with markets.

The PBT-to-NPAT path is clean: effective tax was -0.1% in both years, so there is no tax distortion to unwind. ROE of -4.2% (FY22: -3.4%) is below Annolyse's historical range (mean 8.9%), and net assets shrank by NZ$43.8m through a combination of portfolio losses and distributions exceeding income. The unprecedented-low NPAT margin reading is a mechanical artefact of dividing a negative result by a small recurring-income denominator and should not be read as an operating-margin claim for this issuer.

This briefing cannot assess portfolio composition, holding-level attribution, or fee economics, because those disclosures are not present in the supplied data.